» Authors » Yi-Zhuo Zhang

Yi-Zhuo Zhang

Explore the profile of Yi-Zhuo Zhang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 67
Citations 126
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu J, Wang J, Lu S, Wu Y, Guo L, Shi B, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2025 Jan; 32(6):1733-1737. PMID: 39743258
Objective: To investigate the effect of genetic polymorphism of (rs1801133) on methotrexate (MTX) related toxicity in pediatric mature B-cell lymphoma patients. Methods: Fifty-eight intermediate and high risk patients under 18...
2.
Dou Z, Xia B, Wang C, Xu Y, Zhang Y
Hematology . 2023 Feb; 28(1):2179218. PMID: 36799658
Objective: The incidence of MM in most registries remains stable or showing only a slightly increase. However, prevalence of MM is increasing due to the increase in overall survival in...
3.
Hong Y, Que Y, Hu Y, Shi B, Zhu J, Wang J, et al.
Dis Markers . 2022 Jun; 2022:4752184. PMID: 35756490
Background: Immune-related long noncoding RNAs (IrlncRNAs) are recognized as important prognostic factors in a variety of cancers, but thus far, their prognostic value in pediatric rhabdoid tumor of the kidney...
4.
Hu Y, Wu L, Guan H, Wu S, Liu L, Cai R, et al.
Zhongguo Dang Dai Er Ke Za Zhi . 2021 Sep; 23(9):882-888. PMID: 34535201
Objectives: To evaluate the quality of life and related demographic factors in long-term survivors of childhood non-Hodgkin's lymphoma (NHL). Methods: A retrospective analysis was performed on the medical and demographic...
5.
Li Y, Chen Z, Wang Y, Zhao Z, Zhang Y, Tian C
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2021 Apr; 29(2):469-473. PMID: 33812417
Objective: To investigate the efficacy, safety and prognosis of auto-HSCT between classical and modified conditioning regimen in patients with B-cell non-Hodgkin lymphoma. Methods: 36 patients diagnosed as B-cell non-Hodgkin lymphoma...
6.
Que Y, Zhang X, Liu Z, Zhao J, Pan Q, Wen X, et al.
J Immunother Cancer . 2021 Feb; 9(2). PMID: 33637599
Background: The advent of immune checkpoint therapy has been a tremendous advance in cancer treatment. However, the responses are still insufficient in patients with soft tissue sarcoma (STS). We aimed...
7.
Hu Y, Xia B, Zhang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2020 Dec; 28(6):2084-2088. PMID: 33283746
Exosomes are microvesicles that can be secreting in many kinds of cells, under the condition of normal and pathology. Exosomes contain abundant proteins, miRNAs and RNA fragments, which play an...
8.
Li Y, Hu D, Wang Y, Zhao Z, Cao Z, Zhang Y, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2020 Jun; 28(3):849-854. PMID: 32552946
Objective: To analyze the clinical and pathological characteristics of primary gastrointestinal non-Hodgkin's lymphoma (PGI-NHL) patients, and to explore the factors affecting the patients' survival and prognosis. Methods: The clinical data...
9.
Chen B, Lu S, Peng H, Sun F, Zhu J, Wang J, et al.
Int J Radiat Oncol Biol Phys . 2019 Dec; 106(4):848-856. PMID: 31794839
Purpose: Our purpose was to compare long-term survival outcomes and sequelae between child and adult nasopharyngeal carcinoma (NPC) in the era of intensity modulated radiation therapy. Methods And Materials: Data...
10.
Xu Y, Xu W, Chen J, Tian C, Yang H, Zhao H, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2019 Feb; 27(1):96-103. PMID: 30738454
Objective: To evaluate the quality of life (QOL) on patients with multiple myeloma(MM) during maintenance therapy and to explore the related factors important for QOL. Methods: The demography, clinical and...